| scholarly article | Q13442814 |
| P2093 | author name string | Aydin K | |
| Yaman A | |||
| Vahaboglu H | |||
| Leblebicioglu H | |||
| Oztürk R | |||
| Aygün G | |||
| Balik I | |||
| Coşkunkan F | |||
| Kaygusuz A | |||
| Otkun M | |||
| P2860 | cites work | Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 |
| Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases | Q33747422 | ||
| Antimicrobial susceptibilities of clinical isolates of Acinetobacter baumannii from Singapore | Q33762397 | ||
| A TEM-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa | Q35128838 | ||
| Antimicrobial susceptibility of Acinetobacter species | Q35811495 | ||
| Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa | Q35814019 | ||
| Emergence of Enterococcus as a Significant Pathogen | Q36288793 | ||
| Rapid procedure for detection and isolation of large and small plasmids | Q36320743 | ||
| Characterization of multiple-antibiotic-resistant Salmonella typhimurium stains: molecular epidemiology of PER-1-producing isolates and evidence for nosocomial plasmid exchange by a clone | Q36541933 | ||
| Properties of plasmids responsible for production of extended-spectrum beta-lactamases | Q36752663 | ||
| OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa | Q36753213 | ||
| Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus | Q39411514 | ||
| PCR mapping of integrons reveals several novel combinations of resistance genes | Q39778947 | ||
| OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa | Q39780297 | ||
| Diffusion of beta-lactam antibiotics through liposome membranes reconstituted from purified porins of the outer membrane of Pseudomonas aeruginosa | Q39815788 | ||
| Transposition of the gene encoding a TEM-12 extended-spectrum beta-lactamase | Q39881861 | ||
| Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa | Q39882644 | ||
| Characterization of plasmids conferring resistance to gentamicin and apramycin in strains of Salmonella typhimurium phage type 204c isolated in Britain | Q40272246 | ||
| Origin and impact of plasmid-mediated extended-spectrum beta-lactamases | Q40569192 | ||
| Acquisition by Escherichia coli of plasmid-borne β-lactamases normally confined to Pseudomonas spp | Q41055029 | ||
| The use of analytical isoelectric focusing for detection and identification of beta-lactamases | Q41985418 | ||
| Resistance to extended-spectrum cephalosporins, caused by PER-1 beta-lactamase, in Salmonella typhimurium from Istanbul, Turkey. | Q50142283 | ||
| Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. | Q54158607 | ||
| Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. The Canadian Study Group | Q54260892 | ||
| R Factors from Proteus rettgeri | Q54656071 | ||
| Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance | Q67708324 | ||
| Survey of the prevalence of beta-lactamases amongst 1000 gram-negative bacilli isolated consecutively at the Royal London Hospital | Q67998624 | ||
| In-vitro activity of cephalosporins alone and combined with sulbactam against various strains of Acinetobacter baumannii with different antibiotic resistance profiles | Q71119682 | ||
| [Variation in transfer resistance to cefotaxime, ceftazidime and aztreonam in strains of Acinetobacter sp., Enterobacter sp. and Citrobacter sp. isolated from the same university hospitals] | Q71191577 | ||
| Transferable production of PER-1 beta-lactamase in Pseudomonas aeruginosa | Q72259493 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| multicenter clinical trial | Q6934595 | ||
| P304 | page(s) | 2265-2269 | |
| P577 | publication date | 1997-10-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study | |
| P478 | volume | 41 |
| Q34795807 | Acinetobacter baumannii: emergence of a successful pathogen |
| Q27015109 | Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options |
| Q35183983 | Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact |
| Q39470757 | An SHV-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa |
| Q34456773 | Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment |
| Q27024893 | Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside |
| Q33935402 | BEL-1, a novel clavulanic acid-inhibited extended-spectrum beta-lactamase, and the class 1 integron In120 in Pseudomonas aeruginosa |
| Q42112187 | Biochemical characterization of PER-2 and genetic environment of blaPER-2 |
| Q33978938 | Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae |
| Q26795565 | Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria |
| Q33971388 | Characterization of extended-spectrum beta-lactamase (TEM-52)-producing strains of Salmonella enterica serovar typhimurium with diverse resistance phenotypes |
| Q34141665 | Clinical strain of Pseudomonas aeruginosa carrying a bla(TEM-21) gene located on a chromosomal interrupted TnA type transposon |
| Q30764300 | Cloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene (blaA(CME)) encoding an extended-spectrum class A beta-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER beta-lactamases |
| Q33978798 | Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii |
| Q40931929 | Co-production of ESBL and AmpC β-Lactamases in Clinical Isolates of A. baumannii and A. lwoffii in a Tertiary Care Hospital From Northern India |
| Q24792473 | Comparison in a rat thigh abscess model of imipenem, meropenem and cefoperazone-sulbactam against Acinetobacter baumannii strains in terms of bactericidal efficacy and resistance selection |
| Q34648772 | Complex genetic structures with repeated elements, a sul-type class 1 integron, and the blaVEB extended-spectrum beta-lactamase gene |
| Q27684841 | Crystal Structure of the Extended-Spectrum -Lactamase PER-2 and Insights into the Role of Specific Residues in the Interaction with -Lactams and -Lactamase Inhibitors |
| Q33235526 | Detection and genotyping of SHV beta-lactamase variants by mass spectrometry after base-specific cleavage of in vitro-generated RNA transcripts |
| Q40879778 | Detection of blaPER-1 & blaOxa10 among imipenem resistant isolates of Pseudomonas aeruginosa isolated from burn patients hospitalized in Shiraz Burn Hospital |
| Q39455145 | Detection of carbapenemase-producing Acinetobacter baumannii in a hospital |
| Q35690585 | Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates |
| Q41837614 | Diversity of clavulanic acid-inhibited extended-spectrum β-lactamases in Aeromonas spp. from the Seine River, Paris, France |
| Q33972291 | Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase |
| Q39848627 | Evaluation of the Osiris expert system for identification of beta-lactam phenotypes in isolates of Pseudomonas aeruginosa |
| Q24650618 | Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases |
| Q24550671 | Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat |
| Q24534999 | Extended-spectrum beta-lactamases: a clinical update |
| Q39954478 | Functional and structural characterization of the genetic environment of an extended-spectrum beta-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India |
| Q33982959 | GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem |
| Q42565040 | Genetic and enzymatic properties of metallo-beta-lactamase VIM-5 from a clinical isolate of Enterobacter cloacae. |
| Q33770194 | Genetic environment and expression of the extended-spectrum beta-lactamase blaPER-1 gene in gram-negative bacteria |
| Q41840717 | HIV-1 group O infection in Cameroon, 1986 to 1998. |
| Q39746493 | High Prevalence of PER-1 Extended-Spectrum β-Lactamase-Producing Acinetobacter spp. in Korea |
| Q40575020 | High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia |
| Q42593622 | Horizontol dissemination of TEM- and SHV-typr beta-lactamase genes-carrying resistance plasmids amongst clonical isolates of Enterobacteriaceae |
| Q33970757 | Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. |
| Q39245554 | Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary |
| Q34737402 | Interspecies dissemination of the bla gene encoding PER-1 extended-spectrum β-lactamase |
| Q33976426 | Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene |
| Q37119858 | Molecular characterization of the gene encoding a new AmpC beta-lactamase in a clinical strain of acinetobacter genomic species 3 |
| Q33975793 | Molecular detection of antimicrobial resistance |
| Q46735380 | Molecular epidemiology of PER-1 extended spectrum beta-lactamase among gram-negative bacteria isolated at a tertiary care hospital |
| Q36295402 | Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals |
| Q33970904 | Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand |
| Q33711902 | Multidrug resistant Acinetobacter |
| Q34782040 | Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy |
| Q34045409 | Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France. |
| Q40882602 | Nosocomial outbreak of extended-spectrum beta-lactamase SHV-5-producing isolates of Pseudomonas aeruginosa in Athens, Greece |
| Q37511391 | Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward |
| Q33702898 | OXA-16, a further extended-spectrum variant of OXA-10 beta-lactamase, from two Pseudomonas aeruginosa isolates |
| Q39470875 | OXA-17, a further extended-spectrum variant of OXA-10 beta-lactamase, isolated from Pseudomonas aeruginosa |
| Q33979698 | OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain |
| Q52367440 | On Burkholderiales order microorganisms and cystic fibrosis in Russia. |
| Q36098603 | Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex |
| Q33967629 | Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital |
| Q34106810 | Plasmidic extended-spectrum beta-lactamases in Vibrio cholerae O1 El Tor isolates in Argentina. |
| Q33660431 | Practical approach for detection and identification of OXA-10-derived ceftazidime-hydrolyzing extended-spectrum beta-lactamases |
| Q34170291 | Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy: a two-year study in 16 hospitals. |
| Q51798794 | Prevalence characterization of extended-spectrum beta-lactamases among Escherichia coli isolates collected in Zhengzhou. |
| Q42577909 | Prevalence of PER and VEB Type Extended Spectrum Betalactamases among Multidrug Resistant Acinetobacter baumannii Isolates in North-West of Iran |
| Q38865069 | Prevalence of PER-1- type Extended-Spectrum Beta-Lactamaes in Clinical Strains of Pseudomonas aeruginosa Isolated from Tabriz, Iran |
| Q34113057 | Prospective survey of beta-lactamases produced by ceftazidime- resistant Pseudomonas aeruginosa isolated in a French hospital in 2000. |
| Q33236778 | Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase |
| Q34564797 | Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance |
| Q28069941 | Resistance mechanisms |
| Q36295397 | Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation |
| Q41985167 | Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase |
| Q37643714 | Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains. |
| Q41817951 | Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii |
| Q35905605 | The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace |
| Q33938238 | Tn5393d, a complex Tn5393 derivative carrying the PER-1 extended-spectrum beta-lactamase gene and other resistance determinants. |
| Q26991886 | Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections |
| Q41807595 | Trends in production of extended-spectrum beta-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey |
| Q89831081 | Using comparative genomics to understand molecular features of carbapenem-resistant Acinetobacter baumannii from South Korea causing invasive infections and their clinical implications |
| Q35793194 | VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France |
| Q28366074 | VEB-1-like extended-spectrum beta-lactamases in Pseudomonas aeruginosa, Kuwait |
| Q37035803 | β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula |
Search more.